LONG-TERM NON-INTERVENTIONAL SAFETY STUDY OF EMICIZUMAB TREATMENT IN PATIENTS WITH MODERATE HAEMOPHILIA A AND SEVERE BLEEDING PHENOTYPE (STUDY BO44691, PASS)

ENCePP Code of conduct

No

Data sources

• Data source(s):
  FranceCoag

  World Bleeding Disorders Registry

  Dutch Haemophilia Registry
• Data source(s), other:
  UK National Haemophilia Database (UKNHD), American Thrombosis and Hemostasis Network (ATHN) dataset, and Canadian Bleeding Disorders Registry (CBDR)
• Data sources (types):
  Disease registry

Use of a Common Data Model (CDM)

• CDM mapping:
  Yes

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  Unknown